10258 - Focal Segmental Glomerulosclerosis: Management of Complex Patients

Course Directors

Abdallah Geara, M.D., University of Pennsylvania
Michael Moritz, M.D., University of Pittsburgh School of Medicine


This course reviews the clinical and histopathologic features of focal segmental glomerulosclerosis and delineates the efficacy of standard and novel treatment modalities including lipid apheresis.


AMA PRA Category 1 Credits™

Opus Medicus designates this Internet enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Maintenance of Certification (MOC) Credits

In addition to AMA PRA Category 1 Credits™, Opus Medicus designates this course for Specialty Board MOC Program Credits:

1.0 ABIM MOC Points1

Accreditation Statement

Opus Medicus is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Tuition Fees

Course & Credits: Free

Course Dates

Offered Date: 11-Nov-2021
Expiration Date: 10-Nov-2024


After taking this course, participants should understand the pathophysiology of focal segmental glomerulosclerosis and be familiar with treatment options and their efficacy.


- Clinical and histopathologic features of focal segmental glomerulosclerosis (FSGS)

- Approaches to therapy of FSGS

- Treatment of steroid-resistant FSGS

- Novel therapies for steroid-resistant FSGS

- Lipid apheresis for FSGS

Specific topics covered in this AMA PRA Categogy 1 Credit™ online CME course include focal segmental glomerulosclerosis, treatment of FSGS, and lipid apheresis.

American Board of Medical Specialties (ABMS) / Accreditation Council for Graduate Medical Education (ACGME) Competencies

☑  Patient Care (PC)
☑  Medical Knowledge (MK)

Financial Relationship Disclosure and Content Attestation

Dr. Abdallah Geara, course director, discloses that he has consulted for Aurinia Pharmaceuticals, GlaxoSmithKline (GSK), ValenzaBio, Horizon Therapeutic, Travere, and Alnylam, received educational grants from Kaneka and Aurinia Pharmaceuticals, and received research support from Travere Therapeutics. He attests that none of these entities have had an influence on the course content. Dr. Michael Moritz, moderator, discloses that he has consulted and lectured for Alnylum. He attests that they have had no influence on the course content. Dr. Paul VanderLaan, reviewer, discloses that he has consulted in an advisory capacity for Gala Therapeutics, Caris Life Sciences, Foundation Medicine, Flatiron Health, Intuitive Surgical, and Clearview Healthcare Partners. He attests that none of these entities have had an influence on the course content or his review thereof. Dr. Steven R. Tahan, Education Committee Chair, attests that he has no financial relationships with a commercial entity providing health-care related products and/or service. No other person who has provided content for or who can influence the content of this course has disclosed financial relationships with commercial entities that offer healthcare-related products or services relevant to the course content. Financial support for this course has been received from Kaneka Pharma America, LLC, which has had no influence on the course content.

Supported Computer Hardware and Software Configurations2

Supported client computing platforms include:

A broadband Internet connection is required (e.g., cable, DSL, and 3G or 4G wireless). The course presentation is automatically scaled to the size of the display, from 800x480 pixels (minimum supported) to 1920x1200 pixels. On some smart phones, viewing courses may be tedious.

Supported browsers include:

Javascript, cookies, and popups must be enabled on your browser (which is the default configuration for most browsers).

1. Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points for the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) Program, in addition to AMA PRA Category 1 Credits™. Participants will earn MOC points equivalent to the amount of AMA PRA Category 1 credits claimed for the activity. Immediately upon course completion, Opus Medicus will submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

2. The course may also be viewable on other client computing platforms that comply with Internet standards. If you experience technical problems that prevent you from viewing the course, we will promptly issue a full refund upon request.